TY - JOUR
T1 - β-adrenergic stimulation of mouse parotid gland
T2 - Amylase activity and secretory granules during isoproterenol-induced mitosis
AU - Chapola, Antonio
AU - Villa, Nelson
AU - Valle, Luiz B.S.
AU - Oliveira-Filho, Ricardo M.
AU - Minetti, Conceição A.S.A.
PY - 1985
Y1 - 1985
N2 - 1. 1. This paper examines the mitotic activity of parotid glands of groups of mice sacrificed at 1 hr-intervals between 26 and 36 hr after being injected with dl-isoproterenol (IPR, 1 μmol/g, single dose, i.p.). 2. 2. Maximal mitotic activity occurs 35 hr after IPR injection; there is a concomitant rise of amylase activity (64% over control). 3. 3. Mitotic cells showed increased number of secretory granules (N) with regard to interphasic cells. However, the increment of N is paralleled by an increment of the cell section area (A); the N A ratio is thus maintained around 0.45 throughout. 4. 4. These findings suggest that during IPR-induced mitosis of mice parotid cells there is not a blockade of the biosynthetic pathways which lead to the appearance of secretory granules in the cell cytoplasm.
AB - 1. 1. This paper examines the mitotic activity of parotid glands of groups of mice sacrificed at 1 hr-intervals between 26 and 36 hr after being injected with dl-isoproterenol (IPR, 1 μmol/g, single dose, i.p.). 2. 2. Maximal mitotic activity occurs 35 hr after IPR injection; there is a concomitant rise of amylase activity (64% over control). 3. 3. Mitotic cells showed increased number of secretory granules (N) with regard to interphasic cells. However, the increment of N is paralleled by an increment of the cell section area (A); the N A ratio is thus maintained around 0.45 throughout. 4. 4. These findings suggest that during IPR-induced mitosis of mice parotid cells there is not a blockade of the biosynthetic pathways which lead to the appearance of secretory granules in the cell cytoplasm.
UR - http://www.scopus.com/inward/record.url?scp=0022391955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022391955&partnerID=8YFLogxK
U2 - 10.1016/0306-3623(85)90209-5
DO - 10.1016/0306-3623(85)90209-5
M3 - Article
C2 - 2412937
AN - SCOPUS:0022391955
SN - 0306-3623
VL - 16
SP - 419
EP - 421
JO - General Pharmacology
JF - General Pharmacology
IS - 4
ER -